文献速递心境障碍儿童青少年精神

IMPACT试验:CBT与短期精神分析心理治疗对比简易心理社会干预治疗青少年单相重性抑郁

Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.
PubMed 文献 · Lancet Psychiatry · 2016-12-01

IMPACT多中心实用观察者盲随机对照优效性试验纳入470例11-17岁DSM-IV单相重性抑郁障碍青少年,随机分至CBT、短期精神分析心理治疗或简易心理社会干预。主要结局为36、52、86周自报抑郁症状(MFQ)。CBT与短期精神分析心理治疗在36、52、86周自报抑郁症状无显著差异;两种心理治疗对比简易心理社会干预在36、52、86周均无优效性。

要点

  • CBT与短期精神分析心理治疗在36、52、86周自报抑郁症状无显著差异。
  • CBT或短期精神分析心理治疗对比简易心理社会干预在36、52、86周均无优效性。
  • 三组躯体不良事件与试验干预总成本无显著差异。

核心结论

  • CBT或短期精神分析心理治疗对比简易心理社会干预在维持治疗后12个月抑郁症状减轻方面无优效性证据。
  • 短期精神分析心理治疗与CBT疗效相当,两者连同简易心理社会干预为就诊于常规专科CAMHS的中重度抑郁青少年提供额外心理治疗选择。

研究设计与样本

  • 多中心、实用、观察者盲、随机对照优效性试验(IMPACT),在英国三个地区15个NHS儿童青少年心理健康服务(CAMHS)诊所开展。
  • 纳入470例11-17岁DSM-IV单相重性抑郁障碍青少年,按1:1:1随机分至CBT、短期精神分析心理治疗或简易心理社会干预,随机化按年龄、性别、自报抑郁总分和地区进行随机最小化。
  • 主要结局为36、52、86周自报抑郁症状(MFQ),主要分析为意向治疗分析;465例构成意向治疗人群,392例(84%)有主要分析可用数据。

主要发现

  • 三组躯体不良事件(自报呼吸问题、睡眠障碍、嗜睡或疲倦、恶心、出汗、坐立不安或过度活跃)无差异,试验干预总成本无显著差异。

关键数值与推荐

  • 主要结局为36、52、86周自报抑郁症状,采用自报情绪与感受问卷(MFQ)测量。
  • CBT与短期精神分析心理治疗在36、52、86周自报抑郁症状无显著差异。
  • CBT或短期精神分析心理治疗对比简易心理社会干预在36、52、86周均无优效性。

临床怎么用

  • 对就诊于常规专科CAMHS的中重度抑郁青少年,CBT、短期精神分析心理治疗与简易心理社会干预均可作为心理治疗选择。
  • 短期精神分析心理治疗与CBT疗效相当,可结合简易心理社会干预为患者提供额外选择。

局限性

  • 主要分析基于392例(84%)有可用数据的患者,并非全部意向治疗人群。
  • 患者和临床医生知晓分组,仅结局评估者设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychological treatments for adolescents with unipolar major depressive disorder are associated with diagnostic remission within 28 weeks in 65-70% of patients. We aimed to assess the medium-term effects and costs of psychological therapies on maintenance of reduced depression symptoms 12 months after treatment. METHODS: We did this multicentre, pragmatic, observer-blind, randomised controlled superiority trial (IMPACT) at 15 National Health Service child and adolescent mental health service (CAMHS) clinics in three regions in England. Adolescent patients (aged 11-17 years) with a diagnosis of DSM IV major depressive disorder were randomly assigned (1:1:1), via a web-based randomisation service, to receive cognitive behavioural therapy (CBT) or short-term psychoanalytical therapy versus a reference brief psychological intervention. Randomisation was stochastically minimised by age, sex, self-reported depression sum score, and region. Patients and clinicians were aware of group allocation, but allocation was concealed from outcome assessors. Patients were followed up and reassessed at weeks 6, 12, 36, 52, and 86 post-randomisation. The primary outcome was self-reported depression symptoms at weeks 36, 52, and 86, as measured with the self-reported Mood and Feelings Questionnaire (MFQ). Because our aim was to compare the two psychological therapies with the brief psychosocial intervention, we first established whether CBT was inferior to short-term psychoanalytical psychotherapy for the same outcome. Primary analysis was by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN83033550. FINDINGS: Between June 29, 2010, and Jan 17, 2013, we randomly assigned 470 patients to receive the brief psychosocial intervention (n=158), CBT (n=155), or short-term psychoanalytical therapy (n=157); 465 patients comprised the intention-to-treat population. 392 (84%) patients had available data for primary analysis by the end of follow-up. Treatment fidelity and differentiation were established between the three interventions. The median number of treatment sessions differed significantly between patients in the brief psychosocial intervention group (n=6 [IQR 4-11]), CBT group (n=9 [5-14]), and short-term psychoanalytical therapy group (n=11 [5-23]; p<0·0001), but there was no difference between groups in the average duration of treatment (27·5 [SD 21·5], 24·9 [17·7], 27·9 [16·8] weeks, respectively; Kruskal-Wallis p=0·238). Self-reported depression symptoms did not differ significantly between patients given CBT and those given short-term psychoanalytical therapy at weeks 36 (treatment effect 0·179, 95% CI -3·731 to 4·088; p=0·929), 52 (0·307, -3·161 to 3·774; p=0·862), or 86 (0·578, -2·948 to 4·104; p=0·748). These two psychological treatments had no superiority effect compared with brief psychosocial intervention at weeks 36 (treatment effect -3·234, 95% CI -6·611 to 0·143; p=0·061), 52 (-2·806, -5·790 to 0·177; p=0·065), or 86 (-1·898, -4·922 to 1·126; p=0·219). Physical adverse events (self-reported breathing problems, sleep disturbances, drowsiness or tiredness, nausea, sweating, and being restless or overactive) did not differ between the groups. Total costs of the trial interventions did not differ significantly between treatment groups. INTERPRETATION: We found no evidence for the superiority of CBT or short-term psychoanalytical therapy compared with a brief psychosocial intervention in maintenance of reduced depression symptoms 12 months after treatment. Short-term psychoanalytical therapy was as effective as CBT and, together with brief psychosocial intervention, offers additional patient choice for psychological therapy, alongside CBT, for adolescents with moderate to severe depression who are attending routine specialist CAMHS clinics. FUNDING: National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme, and the Department of Health.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Goodyer IM, Reynolds S, Barrett B, et al. Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial. Lancet Psychiatry. 2016. PMID: 27914903. doi:10.1016/S2215-0366(16)30378-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。